Skip to main content
Top
Published in: Indian Journal of Hematology and Blood Transfusion 2/2019

01-04-2019 | Correspondence

A Case Report of a Rare Rh Phenotype: D—

Authors: Maryam Samareh Salavati Pour, Saeed Soleimany, Narges Ghasemimehr, Roohollah Mirzaee Khalilabadi

Published in: Indian Journal of Hematology and Blood Transfusion | Issue 2/2019

Login to get access

Excerpt

Rh blood group (ISBT: 004) is the second major blood grouping system in addition to ABO, which was first described 60 years ago [1, 2]. Rh factor is an inherited blood protein or antigen on red blood cells [2]. This system includes at least 45 independent antigens from which D, C, c, E, and e are more important for transfusion medicine [3]. Among Rh antigens, e is the most common antigen (98.3%), followed by D (94.2%), C (88.11%), c (54.5%), and E (18.6%) [4]. Rh blood group antigens are highly complicated because of polymorphism in genes encoding them [5]. D and CE proteins/antigens in the Rh blood group system are encoded by RHD and RHCE genes stretching along a 75 kb sequence located on chromosome 1p36.11. Each Rh gene consists of 10 exons that are highly homologous with 93.8% amino acid identity, and RHAG protein on RBC surface is necessary for the expression of Rh antigens. Because of high immunogenicity, D antigen has been recognized as the most important Rh antigen that is used for Rh blood grouping [3]. One of the rare Rh phenotypes is D—, which was first described in 1950 by Race and Sanger. In this phenotype, RHCE proteins are not expressed on RBC membrane. After immune stimulus, individuals with D— phenotype produce an alloantibody known as AntiRh17 (AntiHr0) against CcEe antigens that can lead to the development of a hemolytic transfusion reaction (HTR) or hemolytic disease of newborn (HDN) [68]. Several genetic bases have been known to be responsible for this phenotype: (1) reduced transcription of CE gene, (2) RHCE deletion, (3) gene hybridization between RHD and RHCE genes because of their highly homologous nature. In the description of the last theory, studies showed that a hybrid gene only produced the D antigen [9, 10]. Immunoblotting techniques showed that the expression of D antigen and ICAM4 (LW) was increased whereas CD44 antigen and related blood group antigens were reduced [6]. Herewith, we have reported a case of a woman with rare D— phenotype. …
Literature
2.
go back to reference Avent ND, Reid ME (2000) The Rh blood group system: a review. Blood Transfus Trasfusione del sangue 95(2):375–387 Avent ND, Reid ME (2000) The Rh blood group system: a review. Blood Transfus Trasfusione del sangue 95(2):375–387
4.
go back to reference Gundrajukuppam DK, Vijaya SBK, Rajendran A, Sarella JD (2016) Prevalence of principal Rh Blood Group Antigens in Blood Donors at the Blood Bank of a Tertiary Care Hospital in Southern India. J Clin Diagn Res JCDR 10(5):EC07–EC10PubMed Gundrajukuppam DK, Vijaya SBK, Rajendran A, Sarella JD (2016) Prevalence of principal Rh Blood Group Antigens in Blood Donors at the Blood Bank of a Tertiary Care Hospital in Southern India. J Clin Diagn Res JCDR 10(5):EC07–EC10PubMed
5.
go back to reference Flegel WA (2007) The genetics of the Rhesus blood group system. Blood Transfus Trasfusione del sangue 5(2):50–57PubMed Flegel WA (2007) The genetics of the Rhesus blood group system. Blood Transfus Trasfusione del sangue 5(2):50–57PubMed
6.
go back to reference Flatt JF, Musa RH, Ayob Y, Hassan A, Asidin N, Yahya NM et al (2012) Study of the D– phenotype reveals erythrocyte membrane alterations in the absence of RHCE. Br J Haematol 158(2):262–273CrossRefPubMed Flatt JF, Musa RH, Ayob Y, Hassan A, Asidin N, Yahya NM et al (2012) Study of the D– phenotype reveals erythrocyte membrane alterations in the absence of RHCE. Br J Haematol 158(2):262–273CrossRefPubMed
7.
go back to reference Ochoa-Garay G, Moulds JM, Cote J, Kresie L, Garaizar A, Goldman M et al (2013) New RHCE variant alleles encoding the D— phenotype. Transfusion 53(11 Suppl 2):3018–3023PubMed Ochoa-Garay G, Moulds JM, Cote J, Kresie L, Garaizar A, Goldman M et al (2013) New RHCE variant alleles encoding the D— phenotype. Transfusion 53(11 Suppl 2):3018–3023PubMed
8.
go back to reference Salamat N, Bhatti FA, Hussain A (2004) Anti-Rh17(Anti-Hr0): a rare Diagnostic and Management Problem. Pak Med Associ 54(4):215–218 Salamat N, Bhatti FA, Hussain A (2004) Anti-Rh17(Anti-Hr0): a rare Diagnostic and Management Problem. Pak Med Associ 54(4):215–218
9.
go back to reference Cherif-Zahar B, Raynal V, Cartron JP (1996) Lack of RHCE-encoded proteins in the D– phenotype may result from homologous recombination between the two RH genes. Blood 88(4):1518–1520PubMed Cherif-Zahar B, Raynal V, Cartron JP (1996) Lack of RHCE-encoded proteins in the D– phenotype may result from homologous recombination between the two RH genes. Blood 88(4):1518–1520PubMed
10.
go back to reference Okuda H, Fujiwara H, Omi T, Iwamoto S, Kawano M, Ishida T et al (2000) A Japanese propositus with D– phenotype characterized by the deletion of both the RHCE gene and D1S80 locus situated in chromosome 1p and the existence of a new CE-D-CE hybrid gene. J Hum Genet 45(3):142–153CrossRefPubMed Okuda H, Fujiwara H, Omi T, Iwamoto S, Kawano M, Ishida T et al (2000) A Japanese propositus with D– phenotype characterized by the deletion of both the RHCE gene and D1S80 locus situated in chromosome 1p and the existence of a new CE-D-CE hybrid gene. J Hum Genet 45(3):142–153CrossRefPubMed
11.
go back to reference Elsayid M, Al Qahtani FS, Al Qarni AM, Almajed F, Al Saqri F, Qureshi S (2017) Determination of the frequency of the most immunogenic Rhesus antigens among Saudi donors in King Abdulaziz Medical City–Riyadh. J Nat Sci Biol Med 8(1):56–59CrossRefPubMedPubMedCentral Elsayid M, Al Qahtani FS, Al Qarni AM, Almajed F, Al Saqri F, Qureshi S (2017) Determination of the frequency of the most immunogenic Rhesus antigens among Saudi donors in King Abdulaziz Medical City–Riyadh. J Nat Sci Biol Med 8(1):56–59CrossRefPubMedPubMedCentral
Metadata
Title
A Case Report of a Rare Rh Phenotype: D—
Authors
Maryam Samareh Salavati Pour
Saeed Soleimany
Narges Ghasemimehr
Roohollah Mirzaee Khalilabadi
Publication date
01-04-2019
Publisher
Springer India
Published in
Indian Journal of Hematology and Blood Transfusion / Issue 2/2019
Print ISSN: 0971-4502
Electronic ISSN: 0974-0449
DOI
https://doi.org/10.1007/s12288-019-01089-7

Other articles of this Issue 2/2019

Indian Journal of Hematology and Blood Transfusion 2/2019 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine